{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:42:18Z","timestamp":1793727738720,"version":"4.6.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005247","name":"University of British Columbia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005247","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000046","name":"National Research Council Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000046","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000190","name":"University of Alberta","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000190","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Inorganic Biochemistry"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jinorgbio.2022.111936","type":"journal-article","created":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T11:40:38Z","timestamp":1658144438000},"page":"111936","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Trastuzumab-conjugated oxine-based ligand for [89Zr]Zr4+ immunoPET"],"prefix":"10.1016","volume":"235","author":[{"given":"Lily","family":"Southcott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Wharton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Rousseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Merkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"B\u00e9nard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Orvig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinorgbio.2022.111936_bb0005","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3390\/antib9030034","article-title":"Monoclonal antibodies in cancer therapy","volume":"9","author":"Zahavi","year":"2020","journal-title":"Antibodies."},{"key":"10.1016\/j.jinorgbio.2022.111936_bb0010","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1007\/s11033-018-4427-x","article-title":"Monoclonal antibodies in cancer immunotherapy","volume":"45","author":"Kimiz-Gebologlu","year":"2018","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.jinorgbio.2022.111936_bb0015","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1016\/S1470-2045(16)30030-4","article-title":"Antibody\u2013drug conjugates for cancer therapy","volume":"17","author":"Thomas","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jinorgbio.2022.111936_bb0020","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41571-021-00470-8","article-title":"Unlocking the potential of antibody\u2013drug conjugates for cancer therapy","volume":"18","author":"Drago","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jinorgbio.2022.111936_bb0025","doi-asserted-by":"crossref","DOI":"10.1177\/1536012118801223","article-title":"Application of immuno-PET in antibody\u2013drug conjugate development","volume":"17","author":"Carmon","year":"2018","journal-title":"Mol. Imaging"},{"key":"10.1016\/j.jinorgbio.2022.111936_bb0030","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/jlcr.3607","article-title":"PET radiometals for antibody labeling","volume":"61","author":"Aluicio-Sarduy","year":"2018","journal-title":"J. Label. Compd. Radiopharm."},{"key":"10.1016\/j.jinorgbio.2022.111936_bb0035","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1021\/acs.chemrev.9b00738","article-title":"ImmunoPET: concept, design, and applications","volume":"120","author":"Wei","year":"2020","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2022.111936_bb0040","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1039\/c3cc41554f","article-title":"Tumour targeting with radiometals for diagnosis and therapy","volume":"49","author":"Ramogida","year":"2013","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jinorgbio.2022.111936_bb0045","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.nucmedbio.2012.08.004","article-title":"PET imaging with 89Zr: From radiochemistry to the clinic","volume":"40","author":"Deri","year":"2013","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.jinorgbio.2022.111936_bb0050","first-page":"655","article-title":"Long-lived positron emitters zirconium-89 and iodine-124 for scouting of therapeutic radioimmunoconjugates with PET","volume":"18","author":"Verel","year":"2003","journal-title":"Cancer Biother. Radiopharm."},{"key":"10.1016\/j.jinorgbio.2022.111936_bb0055","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2967\/jnumed.119.230961","article-title":"Total-body PET and highly stable chelators together enable meaningful 89Zr-antibody-PET studies up to 30 days post-injection","volume":"61","author":"Berg","year":"2019","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jinorgbio.2022.111936_bb0060","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1021\/acs.chemrev.8b00281","article-title":"Radioactive transition metals for imaging and therapy","volume":"119","author":"Boros","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2022.111936_bb0065","doi-asserted-by":"crossref","first-page":"6168","DOI":"10.1039\/c0dt01595d","article-title":"A practical guide to the construction of radiometallated bioconjugates for positron emission tomography","volume":"40","author":"Zeglis","year":"2011","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2022.111936_bb0070","doi-asserted-by":"crossref","first-page":"11523","DOI":"10.1039\/C4CC05558F","article-title":"An octadentate bifunctional chelating agent for the development of stable zirconium-89 based molecular imaging probes","volume":"50","author":"Patra","year":"2014","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jinorgbio.2022.111936_bb0075","doi-asserted-by":"crossref","first-page":"4884","DOI":"10.1039\/C4DT02978J","article-title":"Tripodal tris(hydroxypyridinone) ligands for immunoconjugate PET imaging with 89Zr4+: comparison with desferrioxamine-B","volume":"44","author":"Ma","year":"2015","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2022.111936_bb0080","doi-asserted-by":"crossref","first-page":"11889","DOI":"10.1039\/C6CC05961A","article-title":"A desferrioxamine B squaramide ester for the incorporation of zirconium-89 into antibodies","volume":"52","author":"Rudd","year":"2016","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jinorgbio.2022.111936_bb0085","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s00259-009-1263-1","article-title":"p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging","volume":"37","author":"Perk","year":"2010","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.jinorgbio.2022.111936_bb0090","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nprot.2010.13","article-title":"Conjugation and radiolabeling of monoclonal antibodies with zirconium-89 for PET imaging using the bifunctional chelate p-isothiocyanatobenzyl-desferrioxamine","volume":"5","author":"Vosjan","year":"2010","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jinorgbio.2022.111936_bb0095","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s00259-016-3499-x","article-title":"Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for 89Zr-immuno-PET","volume":"44","author":"Vugts","year":"2017","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.jinorgbio.2022.111936_bb0100","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/s00259-020-05002-7","article-title":"Head-to-head comparison of DFO* and DFO chelators: selection of the best candidate for clinical 89Zr-immuno-PET","volume":"48","author":"Chomet","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.jinorgbio.2022.111936_bb0105","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1021\/jm500389b","article-title":"Alternative chelator for 89 Zr radiopharmaceuticals: radiolabeling and evaluation of 3,4,3-(LI-1,2-HOPO)","volume":"57","author":"Deri","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111936_bb0110","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1021\/acs.bioconjchem.5b00572","article-title":"p -SCN-Bn-HOPO: a superior bifunctional chelator for 89Zr immunoPET","volume":"26","author":"Deri","year":"2015","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111936_bb0115","doi-asserted-by":"crossref","first-page":"7657","DOI":"10.1021\/acs.chemrev.8b00254","article-title":"Hydroxypyridinone journey into metal chelation","volume":"118","author":"Cilibrizzi","year":"2018","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2022.111936_bb0120","doi-asserted-by":"crossref","first-page":"18082","DOI":"10.1021\/acs.inorgchem.1c02709","article-title":"[Zr(pypa)]: thermodynamically stable and kinetically inert binary nonadentate complex for radiopharmaceutical applications","volume":"60","author":"Southcott","year":"2021","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111936_bb0125","doi-asserted-by":"crossref","first-page":"3874","DOI":"10.1039\/D0DT04230G","article-title":"High denticity oxinate-linear-backbone chelating ligand for diagnostic radiometal ions [111In]In3+ and [89Zr]Zr4+","volume":"50","author":"Southcott","year":"2021","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2022.111936_bb0130","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/jlcr.3901","article-title":"Production of [89Zr]Oxinate4 and cell radiolabeling for human use","volume":"64","author":"Massicano","year":"2020","journal-title":"J. Label. Compd. Radiopharm."},{"key":"10.1016\/j.jinorgbio.2022.111936_bb0135","doi-asserted-by":"crossref","first-page":"14851","DOI":"10.1039\/C4DT01928H","article-title":"Synthesis and characterisation of zirconium complexes for cell tracking with Zr-89 by positron emission tomography","volume":"43","author":"Ferris","year":"2014","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2022.111936_bb0140","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s00259-014-2945-x","article-title":"[89Zr]Oxinate4 for long-term in vivo cell tracking by positron emission tomography","volume":"42","author":"Charoenphun","year":"2015","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.jinorgbio.2022.111936_bb0145","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.nucmedbio.2020.09.002","article-title":"A kit formulation for the preparation of [89Zr]Zr(oxinate)4 for PET cell tracking: white blood cell labelling and comparison with [111In]In(oxinate)3","volume":"90\u201391","author":"Man","year":"2020","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.jinorgbio.2022.111936_bb0150","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.7150\/thno.40403","article-title":"PET imaging of liposomal glucocorticoids using 89Zr-oxine: theranostic applications in inflammatory arthritis","volume":"10","author":"Gawne","year":"2020","journal-title":"Theranostics."},{"key":"10.1016\/j.jinorgbio.2022.111936_bb0155","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.2147\/DDDT.S49763","article-title":"8-Hydroxyquinolines: a review of their metal chelating properties and medicinal applications","volume":"7","author":"Prachayasittikul","year":"2013","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.jinorgbio.2022.111936_bb0160","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.3390\/molecules25184321","article-title":"Recent advances in the synthesis and biological activity of 8-hydroxyquinolines","volume":"25","author":"Saadeh","year":"2020","journal-title":"Molecules."},{"key":"10.1016\/j.jinorgbio.2022.111936_bb0165","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.poly.2016.02.025","article-title":"Biotin-8-hydroxyquinoline conjugates and their metal complexes: Exploring the chemical properties and the antioxidant activity","volume":"110","author":"Turnaturi","year":"2016","journal-title":"Polyhedron."},{"key":"10.1016\/j.jinorgbio.2022.111936_bb0170","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0003-2670(98)00624-2","article-title":"Synthesis and characterisation of 8-hydroxyquinoline\u2013bovine serum albumin conjugates as metal ion chelating proteins","volume":"378","author":"Giraudi","year":"1999","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jinorgbio.2022.111936_bb0175","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.3390\/molecules25184174","article-title":"8-Hydroxyquinoline glycoconjugates containing sulfur at the sugar anomeric position\u2014synthesis and preliminary evaluation of their cytotoxicity","volume":"25","author":"Krawczyk","year":"2020","journal-title":"Molecules."},{"key":"10.1016\/j.jinorgbio.2022.111936_bb0180","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/cplu.201402450","article-title":"Cyclodextrin 3-functionalized with 8-hydroxyquinoline as an antioxidant inhibitor of metal-induced amyloid aggregation","volume":"80","author":"Oliveri","year":"2015","journal-title":"Chempluschem."},{"key":"10.1016\/j.jinorgbio.2022.111936_bb0185","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1021\/acs.inorgchem.8b01208","article-title":"H2hox: dual-channel oxine-derived acyclic chelating ligand for 68Ga radiopharmaceuticals","volume":"58","author":"Wang","year":"2019","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111936_bb0190","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.1021\/acs.inorgchem.0c00168","article-title":"H2CHXhox: rigid cyclohexane-reinforced nonmacrocyclic chelating ligand for [nat\/67\/68Ga]Ga3+","volume":"59","author":"Wang","year":"2020","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111936_bb0195","doi-asserted-by":"crossref","first-page":"5728","DOI":"10.1021\/acs.inorgchem.0c00509","article-title":"Chelation in One Fell swoop: optimizing ligands for smaller radiometal ions","volume":"59","author":"Choudhary","year":"2020","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111936_bb0200","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.bmcl.2017.01.052","article-title":"Design, synthesis and evaluation of novel bifunctional tetrahydroxamate chelators for PET imaging of 89Zr-labeled antibodies, Bioorganic Med","volume":"27","author":"Rousseau","year":"2017","journal-title":"Chem. Lett."},{"key":"10.1016\/j.jinorgbio.2022.111936_bb0205","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.bmcl.2018.01.067","article-title":"Synthesis and evaluation of bifunctional tetrahydroxamate chelators for labeling antibodies with 89Zr for imaging with positron emission tomography, Bioorganic Med","volume":"28","author":"Rousseau","year":"2018","journal-title":"Chem. Lett."},{"key":"10.1016\/j.jinorgbio.2022.111936_bb0210","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1021\/acs.bioconjchem.0c00087","article-title":"A systematic evaluation of antibody modification and 89Zr-radiolabeling for optimized immuno-PET","volume":"32","author":"Sharma","year":"2021","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111936_bb0215","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0022-1759(84)90435-6","article-title":"Determination of the immunoreactive function of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess","volume":"72","author":"Lindmo","year":"1984","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jinorgbio.2022.111936_bb0220","doi-asserted-by":"crossref","first-page":"4076","DOI":"10.1021\/acs.inorgchem.1c00152","article-title":"Chemical promiscuity of non-macrocyclic multidentate chelating ligands for radiometal ions: H4neunpa-NH2 vs H4noneunpa","volume":"60","author":"Wharton","year":"2021","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111936_bb0225","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.3390\/molecules24193567","article-title":"Recent advances in bioorthogonal click chemistry for efficient synthesis of radiotracers and radiopharmaceuticals","volume":"24","author":"Mushtaq","year":"2019","journal-title":"Mol."},{"key":"10.1016\/j.jinorgbio.2022.111936_bb0230","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1021\/acs.bioconjchem.6b00561","article-title":"Click chemistry and radiochemistry: the first 10 years","volume":"27","author":"Meyer","year":"2016","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111936_bb0235","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/anie.200903924","article-title":"Thiol\u2013Ene click chemistry","volume":"49","author":"Hoyle","year":"2010","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jinorgbio.2022.111936_bb0240","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1039\/C5PY00168D","article-title":"Thiol\u2013maleimide \u201cclick\u201d chemistry: evaluating the influence of solvent, initiator, and thiol on the reaction mechanism, kinetics, and selectivity","volume":"6","author":"Northrop","year":"2015","journal-title":"Polym. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111936_bb0245","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1038\/sj.onc.1210379","article-title":"Trastuzumab: triumphs and tribulations","volume":"26","author":"Nahta","year":"2007","journal-title":"Oncogene."},{"key":"10.1016\/j.jinorgbio.2022.111936_bb0250","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1021\/acs.bioconjchem.0c00087","article-title":"A systematic evaluation of antibody modification and 89Zr-radiolabeling for optimized immuno-PET","volume":"32","author":"Sharma","year":"2021","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111936_bb0255","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1039\/C3DT51940F","article-title":"H6phospa-trastuzumab: Bifunctional methylenephosphonate-based chelator with 89Zr, 111In and 177Lu","volume":"43","author":"Price","year":"2014","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2022.111936_bb0260","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/3-540-13099-3_2","article-title":"Complexation of iron by siderophores a review of their solution and structural chemistry and biological function","volume":"123","author":"Raymond","year":"1984","journal-title":"Struct. Chem."}],"container-title":["Journal of Inorganic Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0162013422002252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0162013422002252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T15:08:13Z","timestamp":1758985693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0162013422002252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":52,"alternative-id":["S0162013422002252"],"URL":"https:\/\/doi.org\/10.1016\/j.jinorgbio.2022.111936","relation":{},"ISSN":["0162-0134"],"issn-type":[{"value":"0162-0134","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trastuzumab-conjugated oxine-based ligand for [89Zr]Zr4+ immunoPET","name":"articletitle","label":"Article Title"},{"value":"Journal of Inorganic Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinorgbio.2022.111936","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111936"}}